Inflection Medicine, a startup aiming to pioneer genomics-enabled precision medicine, has secured $100K in new funding. The capital infusion comes as the company begins its journey with a specific focus on addressing critical needs within the Neonatal Intensive Care Unit (NICU).
While its initial efforts are concentrated on the NICU, Inflection Medicine has signaled ambitions to expand its technology to address broader medical needs on the horizon, positioning itself for future growth in the precision medicine landscape.














